TY - JOUR AU - Jemal, A. AU - Bray, F. AU - Center, M. M. PY - 2011 DA - 2011// TI - Global cancer statistics JO - CA Cancer J Clin VL - 61 UR - https://doi.org/10.3322/caac.20107 DO - 10.3322/caac.20107 ID - Jemal2011 ER - TY - JOUR AU - Ferlay, J. AU - Steliarova-Foucher, E. AU - Lortet-Tieulent, J. PY - 2013 DA - 2013// TI - Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012 JO - Eur J Cancer VL - 49 UR - https://doi.org/10.1016/j.ejca.2012.12.027 DO - 10.1016/j.ejca.2012.12.027 ID - Ferlay2013 ER - TY - JOUR AU - Argiris, A. AU - Karamouzis, M. V. AU - Raben, D. AU - Ferris, R. L. PY - 2008 DA - 2008// TI - Head and neck cancer JO - Lancet. VL - 371 UR - https://doi.org/10.1016/S0140-6736(08)60728-X DO - 10.1016/S0140-6736(08)60728-X ID - Argiris2008 ER - TY - JOUR AU - Viana, L. S. AU - Silva, F. C. A. AU - Jacome, A. A. A. PY - 2016 DA - 2016// TI - Efficacy and safety of a cisplatin and paclitaxel induction regimen followed by chemoradiotherapy for patients with locally advanced head and neck squamous cell carcinoma JO - Head Neck VL - 38 UR - https://doi.org/10.1002/hed.24137 DO - 10.1002/hed.24137 ID - Viana2016 ER - TY - JOUR AU - Iyer, N. G. AU - Tan, D. S. AU - Tan, V. K. PY - 2015 DA - 2015// TI - Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis JO - Cancer. VL - 121 UR - https://doi.org/10.1002/cncr.29251 DO - 10.1002/cncr.29251 ID - Iyer2015 ER - TY - JOUR AU - Colombo, M. AU - Raposo, G. AU - Théry, C. PY - 2014 DA - 2014// TI - Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles JO - Annu Rev Cell Dev Biol VL - 30 UR - https://doi.org/10.1146/annurev-cellbio-101512-122326 DO - 10.1146/annurev-cellbio-101512-122326 ID - Colombo2014 ER - TY - JOUR AU - Yáñez-Mó, M. AU - Siljander, P. R. M. AU - Andreu, Z. PY - 2015 DA - 2015// TI - Biological properties of extracellular vesicles and their physiological functions JO - J Extracell Vesicles VL - 4 UR - https://doi.org/10.3402/jev.v4.27066 DO - 10.3402/jev.v4.27066 ID - Yáñez-Mó2015 ER - TY - JOUR AU - Hong, C. S. AU - Muller, L. AU - Whiteside, T. L. AU - Boyiadzis, M. PY - 2014 DA - 2014// TI - Plasma exosomes as markers of therapeutic response in patients with acute myeloid leukemia JO - Front Immunol VL - 5 UR - https://doi.org/10.3389/fimmu.2014.00160 DO - 10.3389/fimmu.2014.00160 ID - Hong2014 ER - TY - JOUR AU - Tkach, M. AU - Théry, C. PY - 2016 DA - 2016// TI - Communication by extracellular vesicles: where we are and where we need to go JO - Cell. VL - 164 UR - https://doi.org/10.1016/j.cell.2016.01.043 DO - 10.1016/j.cell.2016.01.043 ID - Tkach2016 ER - TY - JOUR AU - Azmi, A. S. AU - Bao, B. AU - Sarkar, F. H. PY - 2013 DA - 2013// TI - Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review JO - Cancer Metastasis Rev VL - 32 UR - https://doi.org/10.1007/s10555-013-9441-9 DO - 10.1007/s10555-013-9441-9 ID - Azmi2013 ER - TY - JOUR AU - Principe, S. AU - Hui, A. B. AU - Bruce, J. PY - 2013 DA - 2013// TI - Tumor-derived exosomes and microvesicles in head and neck cancer: implications for tumor biology and biomarker discovery JO - Proteomics. VL - 13 UR - https://doi.org/10.1002/pmic.201200533 DO - 10.1002/pmic.201200533 ID - Principe2013 ER - TY - JOUR AU - Ramirez, M. I. AU - Amorim, M. G. AU - Gadelha, C. PY - 2018 DA - 2018// TI - Technical challenges of working with extracellular vesicles JO - Nanoscale. VL - 10 UR - https://doi.org/10.1039/C7NR08360B DO - 10.1039/C7NR08360B ID - Ramirez2018 ER - TY - JOUR AU - Whiteside, T. L. PY - 2016 DA - 2016// TI - Exosomes and tumor-mediated immune suppression JO - J Clin Invest VL - 126 UR - https://doi.org/10.1172/JCI81136 DO - 10.1172/JCI81136 ID - Whiteside2016 ER - TY - JOUR AU - Ludwig, S. AU - Floros, T. AU - Theodoraki, M. N. PY - 2017 DA - 2017// TI - Suppression of lymphocyte functions by plasma exosomes correlates with disease activity in patients with head and neck Cancer JO - Clin Cancer Res VL - 23 UR - https://doi.org/10.1158/1078-0432.CCR-16-2819 DO - 10.1158/1078-0432.CCR-16-2819 ID - Ludwig2017 ER - TY - JOUR AU - Bergmann, C. AU - Strauss, L. AU - Wang, Y. PY - 2008 DA - 2008// TI - T regulatory type 1 cells in squamous cell carcinoma of the head and neck: mechanisms of suppression and expansion in advanced disease JO - Clin CancerRes VL - 14 UR - https://doi.org/10.1158/1078-0432.CCR-07-5126 DO - 10.1158/1078-0432.CCR-07-5126 ID - Bergmann2008 ER - TY - JOUR AU - Filipazzi, P. AU - Burdek, M. AU - Villa, A. AU - Rivoltini, L. AU - Huber, V. PY - 2012 DA - 2012// TI - Recent advances on the role of tumor exosomes in immunosuppression and disease progression JO - SeminCancerBiol. VL - 22 ID - Filipazzi2012 ER - TY - JOUR AU - Peinado, H. AU - Aleckovic, M. AU - Lavotshkin, S. PY - 2012 DA - 2012// TI - Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET JO - NatMed. VL - 18 ID - Peinado2012 ER - TY - JOUR AU - Lefebvre, J. L. AU - Ang, K. K. PY - 2009 DA - 2009// TI - Larynx preservation clinical trial design: key issues and recommendations--a consensus panel summary JO - Head Neck. VL - 31 UR - https://doi.org/10.1002/hed.21081 DO - 10.1002/hed.21081 ID - Lefebvre2009 ER - TY - JOUR AU - Théry, C. AU - Ostrowski, M. AU - Segura, E. PY - 2009 DA - 2009// TI - Membrane vesicles as conveyors of immune responses JO - Nat Rev Immunol VL - 9 UR - https://doi.org/10.1038/nri2567 DO - 10.1038/nri2567 ID - Théry2009 ER - TY - JOUR AU - Tan, K. H. AU - Tan, S. S. AU - Sze, S. K. PY - 2014 DA - 2014// TI - Plasma biomarker discovery in preeclampsia using a novel differential isolation technology for circulating extracellular vesicles JO - Am J Obstet Gynecol VL - 211 UR - https://doi.org/10.1016/j.ajog.2014.03.038 DO - 10.1016/j.ajog.2014.03.038 ID - Tan2014 ER - TY - JOUR AU - Mi, H. AU - Huang, X. AU - Muruganujan, A. PY - 2017 DA - 2017// TI - PANTHER version 11: expanded annotation data from gene ontology and Reactome pathways, and data analysis tool enhancements JO - Nucleic Acids Res VL - 45 UR - https://doi.org/10.1093/nar/gkw1138 DO - 10.1093/nar/gkw1138 ID - Mi2017 ER - TY - JOUR AU - Le, Q. T. AU - Sutphin, P. D. AU - Raychaudhuri, S. PY - 2003 DA - 2003// TI - Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas JO - Clin Cancer Res VL - 9 ID - Le2003 ER - TY - JOUR AU - Gehrmann, M. AU - Specht, H. M. AU - Bayer, C. PY - 2014 DA - 2014// TI - Hsp70--a biomarker for tumor detection and monitoring of outcome of radiation therapy in patients with squamous cell carcinoma of the head and neck JO - Radiat Oncol VL - 9 UR - https://doi.org/10.1186/1748-717X-9-131 DO - 10.1186/1748-717X-9-131 ID - Gehrmann2014 ER - TY - JOUR AU - Singh, R. D. AU - Haridas, N. AU - Patel, J. B. PY - 2010 DA - 2010// TI - Matrix metalloproteinases and their inhibitors: correlation with invasion and metastasis in oral cancer JO - Indian J Clin Biochem VL - 25 UR - https://doi.org/10.1007/s12291-010-0060-8 DO - 10.1007/s12291-010-0060-8 ID - Singh2010 ER - TY - JOUR AU - Lin, C. W. AU - Tseng, S. W. AU - Yang, S. F. PY - 2012 DA - 2012// TI - Role of lipocalin 2 and its complex with matrix metalloproteinase-9 in oral cancer JO - Oral Dis VL - 18 UR - https://doi.org/10.1111/j.1601-0825.2012.01938.x DO - 10.1111/j.1601-0825.2012.01938.x ID - Lin2012 ER - TY - JOUR AU - Su, C. W. AU - Su, B. F. AU - Chiang, W. L. PY - 2017 DA - 2017// TI - Plasma levels of the tissue inhibitor matrix metalloproteinase-3 as a potential biomarker in oral cancer progression JO - Int J Med Sci VL - 14 UR - https://doi.org/10.7150/ijms.17024 DO - 10.7150/ijms.17024 ID - Su2017 ER - TY - STD TI - Sill M, Schröder C, Shen Y, et al. Protein profiling gastric Cancer and neighboring control tissues using high-content antibody microarrays. Microarrays (Basel). 2016;5(3). ID - ref27 ER - TY - JOUR AU - Smith, L. AU - Watson, M. B. AU - O'Kane, S. L. AU - Drew, P. J. AU - Lind, M. J. AU - Cawkwell, L. PY - 2006 DA - 2006// TI - The analysis of doxorubicin resistance in human breast cancer cells using antibody microarrays JO - Mol Cancer Ther VL - 5 UR - https://doi.org/10.1158/1535-7163.MCT-06-0190 DO - 10.1158/1535-7163.MCT-06-0190 ID - Smith2006 ER - TY - JOUR AU - Sreekumar, A. AU - Nyati, M. K. AU - Varambally, S. PY - 2001 DA - 2001// TI - Profiling of cancer cells using protein microarrays: discovery of novel radiation-regulated proteins JO - Cancer Res VL - 61 ID - Sreekumar2001 ER - TY - JOUR AU - Arantes, L. M. R. B. AU - Carvalho, A. C. AU - Melendez, M. E. AU - Lopes Carvalho, A. PY - 2018 DA - 2018// TI - Serum, plasma and saliva biomarkers for head and neck cancer JO - Expert Rev Mol Diagn VL - 18 UR - https://doi.org/10.1080/14737159.2017.1404906 DO - 10.1080/14737159.2017.1404906 ID - Arantes2018 ER - TY - JOUR AU - Zupancic, K. AU - Blejec, A. AU - Herman, A. PY - 2014 DA - 2014// TI - Identification of plasma biomarker candidates in glioblastoma using an antibody-array-based proteomic approach JO - Radiol Oncol VL - 48 UR - https://doi.org/10.2478/raon-2014-0014 DO - 10.2478/raon-2014-0014 ID - Zupancic2014 ER - TY - JOUR AU - Righetti, P. G. AU - Castagna, A. AU - Antonucci, F. PY - 2005 DA - 2005// TI - Proteome analysis in the clinical chemistry laboratory: myth or reality? JO - Clin Chim Acta VL - 357 UR - https://doi.org/10.1016/j.cccn.2005.03.018 DO - 10.1016/j.cccn.2005.03.018 ID - Righetti2005 ER - TY - JOUR AU - Diamandis, E. P. PY - 2004 DA - 2004// TI - Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations JO - Mol Cell Proteomics VL - 3 UR - https://doi.org/10.1074/mcp.R400007-MCP200 DO - 10.1074/mcp.R400007-MCP200 ID - Diamandis2004 ER - TY - JOUR AU - Liu, T. AU - Qian, W. J. AU - Mottaz, H. M. PY - 2006 DA - 2006// TI - Evaluation of multiprotein immunoaffinity subtraction for plasma proteomics and candidate biomarker discovery using mass spectrometry JO - Mol Cell Proteomics VL - 5 UR - https://doi.org/10.1074/mcp.T600039-MCP200 DO - 10.1074/mcp.T600039-MCP200 ID - Liu2006 ER - TY - JOUR AU - Patel, K. AU - Wen, J. AU - Magliocca, K. PY - 2014 DA - 2014// TI - Heat shock protein 90 (HSP90) is overexpressed in p16-negative oropharyngeal squamous cell carcinoma, and its inhibition in vitro potentiates the effects of chemoradiation JO - Cancer Chemother Pharmacol VL - 74 UR - https://doi.org/10.1007/s00280-014-2584-8 DO - 10.1007/s00280-014-2584-8 ID - Patel2014 ER - TY - JOUR AU - Dewyer, N. A. AU - Wolf, G. T. AU - Light, E. AU - Worden, F. AU - Urba, S. AU - Eisbruch, A. AU - Bradford, C. R. AU - Chepeha, D. B. AU - Prince, M. E. AU - Moyer, J. AU - Taylor, J. PY - 2014 DA - 2014// TI - Circulating CD4-positive lymphocyte levels as predictor of response to induction chemotherapy in patients with advanced laryngeal cancer JO - Head Neck. VL - 36 UR - https://doi.org/10.1002/hed.23263 DO - 10.1002/hed.23263 ID - Dewyer2014 ER - TY - JOUR AU - Liu, M. AU - Zhang, X. AU - Hu, C. F. AU - Xu, Q. AU - Zhu, H. X. AU - Xu, N. Z. PY - 2014 DA - 2014// TI - MicroRNA-mRNA functional pairs for cisplatin resistance in ovarian cancer cells JO - Chin J Cancer VL - 33 UR - https://doi.org/10.5732/cjc.013.10136 DO - 10.5732/cjc.013.10136 ID - Liu2014 ER - TY - JOUR AU - Wan, B. AU - Dai, L. AU - Wang, L. PY - 2018 DA - 2018// TI - Knockdown of BRCA2 enhances cisplatin and cisplatin-induced autophagy in ovarian cancer cells JO - Endocr Relat Cancer VL - 25 UR - https://doi.org/10.1530/ERC-17-0261 DO - 10.1530/ERC-17-0261 ID - Wan2018 ER - TY - JOUR AU - Nicholson, R. I. AU - Gee, J. M. AU - Harper, M. E. PY - 2001 DA - 2001// TI - EGFR and cancer prognosis JO - Eur J Cancer VL - 37 UR - https://doi.org/10.1016/S0959-8049(01)00231-3 DO - 10.1016/S0959-8049(01)00231-3 ID - Nicholson2001 ER - TY - JOUR AU - Zhang, Y. AU - Molavi, O. AU - Su, M. AU - Lai, R. PY - 2014 DA - 2014// TI - The clinical and biological significance of STAT1 in esophageal squamous cell carcinoma JO - BMC Cancer VL - 14 UR - https://doi.org/10.1186/1471-2407-14-791 DO - 10.1186/1471-2407-14-791 ID - Zhang2014 ER - TY - JOUR AU - Azimian, H. AU - Dayyani, M. AU - Toossi, M. T. B. AU - Mahmoudi, M. PY - 2018 DA - 2018// TI - Bax/Bcl-2 expression ratio in prediction of response to breast cancer radiotherapy JO - Iran J Basic Med Sci VL - 21 ID - Azimian2018 ER - TY - JOUR AU - Deep, G. AU - Jain, A. K. AU - Ramteke, A. PY - 2014 DA - 2014// TI - SNAI1 is critical for the aggressiveness of prostate cancer cells with low E-cadherin JO - Mol Cancer VL - 13 UR - https://doi.org/10.1186/1476-4598-13-37 DO - 10.1186/1476-4598-13-37 ID - Deep2014 ER - TY - JOUR AU - Tang, X. AU - Jin, L. AU - Cao, P. PY - 2016 DA - 2016// TI - MicroRNA-16 sensitizes breast cancer cells to paclitaxel through suppression of IKBKB expression JO - Oncotarget. VL - 7 ID - Tang2016 ER - TY - JOUR AU - Hsu, H. W. AU - Wall, N. R. AU - Hsueh, C. T. PY - 2014 DA - 2014// TI - Combination antiangiogenic therapy and radiation in head and neck cancers JO - Oral Oncol VL - 50 UR - https://doi.org/10.1016/j.oraloncology.2013.10.003 DO - 10.1016/j.oraloncology.2013.10.003 ID - Hsu2014 ER - TY - JOUR AU - Vassilakopoulou, M. AU - Psyrri, A. AU - Argiris, A. PY - 2015 DA - 2015// TI - Targeting angiogenesis in head and neck cancer JO - Oral Oncol VL - 51 UR - https://doi.org/10.1016/j.oraloncology.2015.01.006 DO - 10.1016/j.oraloncology.2015.01.006 ID - Vassilakopoulou2015 ER - TY - JOUR AU - Bauer, J. A. AU - Trask, D. K. AU - Kumar, B. AU - Los, G. AU - Castro, J. AU - Lee, J. S. AU - Chen, J. AU - Wang, S. AU - Bradford, C. R. AU - Carey, T. E. PY - 2005 DA - 2005// TI - Reversal of cisplatin resistance with a BH3 mimetic, (−)-gossypol, in head and neck cancer cells: role of wild-type p53 and Bcl-xL JO - Mol Cancer Ther VL - 4 UR - https://doi.org/10.1158/1535-7163.MCT-05-0081 DO - 10.1158/1535-7163.MCT-05-0081 ID - Bauer2005 ER - TY - JOUR AU - Ji, X. AU - Jiang, C. AU - Liu, Y. AU - Bu, D. AU - Xiao, S. PY - 2011 DA - 2011// TI - Fas ligand gene transfer effectively induces apoptosis in head and neck cancer cells JO - Acta Otolaryngol VL - 131 UR - https://doi.org/10.3109/00016489.2011.562539 DO - 10.3109/00016489.2011.562539 ID - Ji2011 ER - TY - JOUR AU - Gadhikar, M. A. AU - Sciuto, M. R. AU - Alves, M. V. PY - 2013 DA - 2013// TI - Chk1/2 inhibition overcomes the cisplatin resistance of head and neck cancer cells secondary to the loss of functional p53 JO - Mol Cancer Ther VL - 12 UR - https://doi.org/10.1158/1535-7163.MCT-13-0157 DO - 10.1158/1535-7163.MCT-13-0157 ID - Gadhikar2013 ER -